About Mitoch Pharma Private Limited
Data last updated:
Mitoch Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24139MH1992PTC068819.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹23.15 Lakh. It is led by directors including Vasudev Jamnabihar Masurekar and Yousif Ibrahim Ahmed Qabageh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F 19 – 20 1st Floor Kohinoor Mall Kirol Road Kurla West, Mumbai, Maharashtra, India – 400070.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.39 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.08 Cr (net margin 7%) and EBITDA of ₹1.43 Cr (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 3% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mitoch Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mitochpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressF 19 – 20 1st Floor Kohinoor Mall Kirol Road Kurla West, Mumbai, Maharashtra, India – 400070
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mitoch Pharma Private Limited
The main business activity of Mitoch Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mitoch Pharma Private Limited FY 2025 filings available
Mitoch Pharma Private Limited reported revenue of ₹15.39 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mitoch Pharma Private Limited
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mitoch Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.43 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.08 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mitoch Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mitoch Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mitoch Pharma Private Limited
Mitoch Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| R P Biotech Private Limited | ₹15.48 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Gurdaspur, Punjab, India |
| Geomedics Pharma Private Limited | ₹15.47 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Pune, Maharashtra, India |
| Pharmasys Private Limited | ₹15.46 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Delhi, India |
| Sifam Healthcare Private Limited | ₹15.43 Cr (FY 2022) | •••• | •••• | -6.0% | •••• | Ahmedabad, Gujarat, India |
| Shri Bhagatji Surgicals Private Limited | ₹15.41 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Dadri, Uttar Pradesh, India |
| Mitoch Pharma Private Limited this company | ₹15.39 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Mumbai, Maharashtra, India |
| Ishita Drugs and Industries Limited Listed | ₹15.33 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
| Nuclotec Remedies Private Limited | ₹15.32 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | New Delhi, Delhi, India |
| Stanmark Healthcare Private Limited | ₹15.31 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Vilin Bio Med Limited | ₹15.28 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Hyderabad, Telangana, India |
| Ishita Active Pharma Ingredients Private Limited | ₹15.25 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Mitoch Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mitoch Pharma Private Limited
Mitoch Pharma Private Limited is audited by Nadkarni Date & Associates LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Nadkarni Date & Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mitoch Pharma Private Limited
Mitoch Pharma has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vasudev Jamnabihar Masurekar Also directs: Uniocean Consultancy Private Limited | Director | 30 Sep 1992 | 34 Years 0 Months | Current |
| Yousif Ibrahim Ahmed Qabageh | Director | 30 Sep 1992 | 34 Years 0 Months | Current |
| Raman Hirji Maroo Also directs: Banyan Tree Living and Life Style LLP, Canonical Trading LLP, Shemaroo Entertainment Limited and 3 more | Director | 30 Sep 1992 | 34 Years 0 Months | Current |
| Krish Vijaykumar Panikar | Director | 12 Jul 2022 | 4 Years 2 Months | Current |
| Arjun Vijaykumar Panikar Also directs: Mccoy Pharma Private Limited, Vaks Pharma Private Limited | Director | 21 Aug 2018 | 8 Years 1 Months | Current |
| Siddharth Vijay Panikar Also directs: Mccoy Pharma Private Limited, Vaks Pharma Private Limited, P. N. Packaging Private Limited and 1 more | Director | 21 Aug 2018 | 8 Years 1 Months | Current |
Ownership and Shareholding of Mitoch Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mitoch Pharma Private Limited
Mitoch Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
MSME Payment Delays by Mitoch Pharma Private Limited
Mitoch Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 4 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Mccoy Pharma Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Mitoch Pharma Private Limited
Mitoch Pharma operates one associated brand: Mitoch Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and distribution of innovative pharmaceutical products across categories like diabetic care and pain management. | mitochpharma.com |
Employees and EPFO Compliance at Mitoch Pharma Private Limited
Mitoch Pharma Private Limited has a workforce of 7 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mitoch Pharma Private Limited
Mitoch Pharma Private Limited has 13 board changes on record since 1992: 6 appointments and 7 cessations. The latest: Krish Vijaykumar Panikar ceased to be Additional Director on 30 Sep 2022.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Mitoch Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mitoch Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mitoch Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mitoch Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mitoch Pharma Private Limited
Mitoch Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 1992 (34+ years old) and is registered under CIN U24139MH1992PTC068819.
Mitoch Pharma reported revenue of ₹15.39 Cr for FY 2025 (down 9% YoY).
Mitoch Pharma has 6 current directors:
- Vasudev Jamnabihar Masurekar - Director
- Yousif Ibrahim Ahmed Qabageh - Director
- Raman Hirji Maroo - Director
- Krish Vijaykumar Panikar - Director
- Arjun Vijaykumar Panikar - Director
- Siddharth Vijay Panikar - Director
Mitoch Pharma reported a net profit of ₹1.08 Cr (net margin 7%) and EBITDA of ₹1.43 Cr (EBITDA margin 9.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mitoch Pharma is 16% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 9%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Mitoch Pharma is U24139MH1992PTC068819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mitoch Pharma was incorporated on 30 September 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mitoch Pharma by revenue are R P Biotech Private Limited, Geomedics Pharma Private Limited, Pharmasys Private Limited, Sifam Healthcare Private Limited, Shri Bhagatji Surgicals Private Limited and 5 more, all in the Pharma industry (Formulations).
Krish Vijaykumar Panikar ceased to be Additional Director on 30 Sep 2022. Krish Vijaykumar Panikar was appointed as Director on 12 Jul 2022. Jaya Vijay Panikar ceased to be Director on 20 May 2019. Mitoch Pharma has 13 board changes on record in total.
Mitoch Pharma has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 4 overdue payments to 3 micro and small suppliers. The latest return was filed on 30 Aug 2021.
Mitoch Pharma can be reached through the website mitochpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Mitoch Pharma is at F 19 – 20 1st Floor Kohinoor Mall Kirol Road Kurla West, Mumbai, Maharashtra, India – 400070.